Oscar Health (NYSE:OSCR – Get Free Report) had its price target upped by stock analysts at Robert W. Baird from $27.00 to $33.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Robert W. Baird’s target price indicates a potential upside of 2.34% from the company’s current price.
OSCR has been the topic of several other reports. Barclays reiterated an “overweight” rating and set a $49.00 target price (up from $39.00) on shares of Oscar Health in a research report on Thursday. The Goldman Sachs Group restated a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a report on Tuesday, August 11th. Piper Sandler restated an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a report on Tuesday, July 28th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Finally, Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $28.20.
Read Our Latest Stock Analysis on OSCR
Oscar Health Trading Down 0.6%
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same period in the prior year, the business earned ($0.89) earnings per share. The business’s revenue was up 70.4% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health will post 1.54 EPS for the current fiscal year.
Insider Buying and Selling at Oscar Health
In other news, CEO Mark Bertolini sold 624,244 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the completion of the transaction, the chief executive officer directly owned 7,751,570 shares in the company, valued at approximately $220,764,713.60. The trade was a 7.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the completion of the sale, the chief financial officer owned 1,046,108 shares in the company, valued at approximately $32,900,096.60. This represents a 2.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 4,322,257 shares of company stock valued at $126,818,346 in the last ninety days. Company insiders own 22.64% of the company’s stock.
Institutional Investors Weigh In On Oscar Health
A number of institutional investors and hedge funds have recently modified their holdings of the stock. BIT Capital GmbH raised its holdings in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares during the period. Geode Capital Management LLC increased its position in Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after buying an additional 116,430 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Oscar Health by 22.1% in the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after purchasing an additional 759,837 shares during the period. Bank of America Corp DE increased its position in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after buying an additional 1,922,732 shares during the period. Finally, Assenagon Asset Management S.A. increased its stake in Oscar Health by 1.6% during the second quarter. Assenagon Asset Management S.A. now owns 1,247,992 shares of the company’s stock valued at $35,593,000 after acquiring an additional 20,189 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.
About Oscar Health
Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.
Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.
Featured Stories
- Five stocks we like better than Oscar Health
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
